Patients with acute diverticulitis diagnosed by contrast-enhanced CT may benefit from early colonoscopies for colon cancer screening.
Patients with acute diverticulitis diagnosed by contrast-enhanced CT (CECT) may benefit from early colonoscopies for colon cancer screening, according to an article published in the American Journal of Roentgenology.
Researchers from Harvard Medical School studied endoscopic colonoscopy results of 402 patients who had been diagnosed with acute diverticulitis on CECT between January 2000 and December 2004. The goal of the study was to establish CT criteria as an indication for colonoscopy in this patient population.
The researchers evaluated the sensitivity, specificity, and predictive values of the imaging parameters for prediction of colon cancer. The patients were followed for a mean of 5.3 years. The outcomes were compared between the 235 women and 167 men.
The results showed that of the 402 patients, 71 percent were found to have adenomatous polyps and 2.2 percent were diagnosed with colon cancer (seven women and two men). The odds ratio for diagnosis of colon cancer was 23.35 in patients with mesenteric or retroperitoneal lymph nodes, 4.67 for abscess, and 24.43 in patients with obstruction and localized mass reported on CT.
There was a significant correlation between the location of diverticulitis and cancer. The diagnosis of cancer was made within six months from the date of CECT in eight patients. The odds of cancer were 2.5 times higher in women.
The authors concluded with the recommendation of "early colonoscopy in patients with wall thickness more than 6 mm, abscess, obstruction, or lymph nodes seen on CECT."
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.